PASITHEA THERAPEUTICS CORP. Other General and Administrative Expense
PASITHEA THERAPEUTICS CORP. (KTTA) reported Other General and Administrative Expense of $700 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherGeneralAndAdministrativeExpense · last filed 2026-03-30
- PASITHEA THERAPEUTICS CORP. other general and administrative expense for the quarter ending 2025-12-31 was $0.00.
- PASITHEA THERAPEUTICS CORP. other general and administrative expense for the quarter ending 2025-09-30 was $0.00.
- PASITHEA THERAPEUTICS CORP. other general and administrative expense for the quarter ending 2025-06-30 was $45.00.
- PASITHEA THERAPEUTICS CORP. other general and administrative expense for the quarter ending 2025-03-31 was $655.00.
- PASITHEA THERAPEUTICS CORP. other general and administrative expense for fiscal 2025 was $700.00.
| Period end | Other General and Administrative Expense 3 month | Other General and Administrative Expense 6 month | Other General and Administrative Expense 9 month | Other General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $45.00 derived: sum of 3 quarters · filed 2026-03-30 | $700.00 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $45.00 derived: sum of 2 quarters · filed 2025-11-13 | $700.00 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $45.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $700.00 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | $655.00 10-Q · filed 2025-05-15 | |||
| 2023-03-31 | $271.87K 10-Q · filed 2023-05-12 | |||
| 2022-03-31 | $326.38K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |